Part

Motorcar Parts of America to Report Fiscal 2024 Third Quarter Results; Host Conference Call

Retrieved on: 
Tuesday, February 6, 2024

Motorcar Parts of America, Inc. is a remanufacturer, manufacturer, and distributor of automotive aftermarket parts -- including alternators, starters, wheel bearings and hub assemblies, brake calipers, brake pads, brake rotors, brake master cylinders, brake power boosters, turbochargers, and diagnostic testing equipment utilized in imported and domestic passenger vehicles, light trucks, and heavy-duty applications. Its products are sold to automotive retail outlets and the professional repair market throughout the United States, Canada, and Mexico, with facilities located in California, New York, Mexico, Malaysia, China and India, and administrative offices located in California, Tennessee, Mexico, Singapore, Malaysia, and Canada. In addition, the company’s electrical vehicle subsidiary designs and manufactures testing solutions for performance, endurance, and production of multiple components in the electric power train – providing simulation, emulation, and production applications for the electrification of both automotive and aerospace industries, including electric vehicle charging systems. Additional information is available at www.motorcarparts.com.

Key Points: 
  • Motorcar Parts of America, Inc. (Nasdaq: MPAA) today announced the company will issue results for its fiscal 2024 third quarter on Friday, February 9, 2024.
  • Selwyn Joffe, chairman, president and chief executive officer, and David Lee, chief financial officer, will host an investor conference call the same day at 10:00 a.m. Pacific time to discuss the company’s financial results and operations.
  • For those who are not available to listen to the live broadcast, the call will be archived on Motorcar Parts of America’s website www.motorcarparts.com .
  • A telephone playback of the conference call will also be available from approximately 1:00 p.m. Pacific time on February 9, 2024 through 8:59 p.m. Pacific time on February 16, 2024 by dialing (800) 770-2030 (domestic) or (609) 800-9909 (toll) and using access code: 1545314.

FirstEnergy Ohio Utilities’ Competitive Bidding Process Auction: Information Session for Prospective Bidders on Thursday, February 8, 2024

Retrieved on: 
Tuesday, February 6, 2024

The auction process will lead up to the auction scheduled for March 19, 2024.

Key Points: 
  • The auction process will lead up to the auction scheduled for March 19, 2024.
  • The Information Session for prospective bidders for the February auction is scheduled for Thursday, February 8, 2024.
  • Part 1 Applications from prospective bidders will be accepted starting February 9, 2024, and are due no later than February 20, 2024.
  • For successful Part 1 applicants, the submission window for the Part 2 Application process will begin on February 23, 2024.

Arctic Glacier Enhances North American Distribution Performance with Descartes Strategic Route Planning Solution

Retrieved on: 
Tuesday, February 6, 2024

The solution’s advanced single-pass optimization technology streamlines the strategic route planning process to produce faster and better results than conventional sales and territory planning solutions.

Key Points: 
  • The solution’s advanced single-pass optimization technology streamlines the strategic route planning process to produce faster and better results than conventional sales and territory planning solutions.
  • “We’re pleased to help Arctic Glacier optimally flex its distribution network to address large demand swings and incorporate acquisitions,” said James Wee, General Manager, Routing, Mobile and Telematics at Descartes.
  • “Our advanced strategic route planning solution allows distribution companies to quickly execute network reroutes while producing superior results to legacy planning solutions.
  • Descartes’ strategic route planning solution is a powerful tool for distributors given the accelerating pace of change that distribution businesses are experiencing.”

Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 6, 2024

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced financial results for the fourth quarter and year ended December 31, 2023 and provided a corporate update.

Key Points: 
  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced financial results for the fourth quarter and year ended December 31, 2023 and provided a corporate update.
  • Expects to present updated results from the Phase 1/2 study of vimseltinib in TGCT in the second half of 2024.
  • Expects to initiate a Phase 2 proof-of-concept study of vimseltinib for the treatment of chronic graft versus host disease (cGVHD) in the fourth quarter of 2024.
  • Cost of Sales: Cost of sales were $1.8 million in the fourth quarter of 2023, which includes $0.9 million in cost of product sales, compared to cost of product sales of $0.7 million for the fourth quarter of 2022.

Middleburg Communities to Commence Construction on 260-Unit Build-to-Rent Community in Richmond MSA

Retrieved on: 
Monday, February 5, 2024

Middleburg Communities (“Middleburg”) today announced it has secured financing from Simmons Bank to begin construction of Hamlet Falling Creek, a 260-unit build-to-rent community to be developed along Genito Road in Midlothian, Virginia about 20 minutes southwest of Downtown Richmond.

Key Points: 
  • Middleburg Communities (“Middleburg”) today announced it has secured financing from Simmons Bank to begin construction of Hamlet Falling Creek, a 260-unit build-to-rent community to be developed along Genito Road in Midlothian, Virginia about 20 minutes southwest of Downtown Richmond.
  • The project marks Middleburg’s second build-to-rent community in Midlothian, joining Hamlet Watkins Centre, which is currently under construction.
  • Selim Tay-Agbozo, President of Middleburg Development, stated, “The Richmond MSA possesses many of the fundamentals that drive our investment decisions.
  • Middleburg currently has six built-to-rent communities under construction in Richmond, Charlotte, Charleston, Jacksonville, Huntsville, and Wilmington.

BioCatch Shares Guidance for Consumer Protection against Romance Scams

Retrieved on: 
Monday, February 5, 2024

TEL AVIV, Israel and NEW YORK, Feb. 5, 2024 /PRNewswire/ -- BioCatch, the global leader in digital fraud and money laundering powered by behavioral biometric intelligence, today shared guidance for protecting vulnerable banking customers from modern-day romance scams.  With Valentine's Day 2024 only days away, and authorised payment fraud continuing to skyrocket globally, it is important that the fraud-fighting community share insights on how best to protect victims and identify the perpetrators of romance scams. Scams have undergone a significant evolution in recent years, adjusting to the dynamics of our digital existence, and evolving with our communication preferences and channels. They have also diversified significantly expanding beyond traditional forms to encompass a wider array of deceptive tactics.

Key Points: 
  • UK Finance reports a staggering 26% surge in romance scams during the initial half of 2023, leading to a loss of £18.5 million for consumers.
  • "When it comes to romance scams, or any scam for that matter, banks need to play a critical role in consumer education and protection.
  • BioCatch realized some time ago that a more comprehensive approach was needed to fight romance scams.
  • "Romance scams are particularly cruel and often devastating for victims, leaving them with both broken hearts and empty bank accounts.

BioCatch Shares Guidance for Consumer Protection against Romance Scams

Retrieved on: 
Monday, February 5, 2024

TEL AVIV, Israel and NEW YORK, Feb. 5, 2024 /PRNewswire/ -- BioCatch, the global leader in digital fraud and money laundering powered by behavioral biometric intelligence, today shared guidance for protecting vulnerable banking customers from modern-day romance scams.  With Valentine's Day 2024 only days away, and authorised payment fraud continuing to skyrocket globally, it is important that the fraud-fighting community share insights on how best to protect victims and identify the perpetrators of romance scams.

Key Points: 
  • UK Finance reports a staggering 26% surge in romance scams during the initial half of 2023, leading to a loss of £18.5 million for consumers.
  • "When it comes to romance scams, or any scam for that matter, banks need to play a critical role in consumer education and protection.
  • BioCatch realized some time ago that a more comprehensive approach was needed to fight romance scams.
  • "Romance scams are particularly cruel and often devastating for victims, leaving them with both broken hearts and empty bank accounts.

Verizon unveils a hot ticket for customers with “Verizon Live” in Las Vegas leading up to Super Bowl LVIII

Retrieved on: 
Thursday, February 1, 2024

Join Netflix and Verizon ahead of the big game for a night of exclusive first looks at some of Netflix’s most highly anticipated releases.

Key Points: 
  • Join Netflix and Verizon ahead of the big game for a night of exclusive first looks at some of Netflix’s most highly anticipated releases.
  • Tune into Super Bowl LVIII on Paramount+ and NFL+ (on mobile), accessible for Verizon customers via +play.
  • Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed in 2000 and is one of the world’s leading providers of technology and communications services.
  • Headquartered in New York City and with a presence around the world, Verizon generated revenues of $134.0 billion in 2023.

Aviceda Therapeutics Announces First Patient Dosed in Part 2 of the Phase 2/3 SIGLEC Clinical Trial Assessing AVD-104 for the Treatment of Geographic Atrophy

Retrieved on: 
Thursday, February 1, 2024

“In Part 1 of SIGLEC, we found that AVD-104 had a positive safety profile, and that patients with GA dosed with AVD-104 showed BCVA improvements at 3 months (Found HERE ).

Key Points: 
  • “In Part 1 of SIGLEC, we found that AVD-104 had a positive safety profile, and that patients with GA dosed with AVD-104 showed BCVA improvements at 3 months (Found HERE ).
  • Patients will be dosed for 12 months, with the opportunity to remain in the study for an additional 12 months.
  • Those assigned to treatment with AVD-104 will receive either low-dose AVD-104, high-dose AVD-104, or the active comparator.
  • Numerous other visual functional and anatomic efficacy measures will also be explored and compared between AVD-104 and the active comparator.

Solera's Vehicle Solutions Auto/Mate Forges Strategic Partnership with IPS ScanIt Parts for Exclusive Parts Scanning Solution

Retrieved on: 
Wednesday, January 31, 2024

The integration of ScanIt Parts into the Auto/Mate platform is a testament to the seamless connectivity facilitated by the Open/Mate API platform.

Key Points: 
  • The integration of ScanIt Parts into the Auto/Mate platform is a testament to the seamless connectivity facilitated by the Open/Mate API platform.
  • Auto/Mate dealers will benefit not only from the innovative features of ScanIt Parts but also from the convenience and integration capabilities that come with the partnership.
  • "We are excited to expand our collaboration with Auto/Mate and provide their dealers with a comprehensive parts scanning solution,” said Dale Zimmer, VP Software Development at IPS.
  • "ScanIt Parts is designed to simplify and enhance dealership inventory management, and we look forward to helping Auto/Mate dealers optimize their parts processes.